Fig 1.
Prostate location and MR imagine plane.
(Yellow: Transition zone; Blue: Peripheral zone.). (a, b, c.) Axial fat-saturated T2WI MR images of prostate. (d, e, f.) Sagittal fat-saturated T2WI MR images of prostate. (b, e.) Blue line (1, 2, 3.) depicting the width, height and length of transition zone. (c, f.) Red line (1, 2, 3.) depicting the width, height and length of prostate.
Table 1.
Clinical characteristics of patients with no PCa and PCa at the initial biopsy.
Table 2.
Clinical characteristics of patients with no HR-PCa and HR-PCa at the initial biopsy.
Table 3.
Multivariate logistic regression analysis of predictors associated with PCa at the initial biopsy.
Table 4.
Multivariate logistic regression analysis of predictors associated with HR-PCa at the initial biopsy (backward elimination selection procedure).
Table 5.
The AUC and cut-off values for predicting biopsy outcome and their sensitivity, specificity, positive and negative likelihood ratios for PCa and no PCa.
Table 6.
The AUC and cut-off values for predicting biopsy outcome and their sensitivity, specificity, positive and negative likelihood ratios for HR-PCa and no HR-PCa.
Fig 2.
Receiver-operating characteristic curves depicting the accuracy of predictors of PCa (a.) and HR-PCa (b.) at the initial biopsy. Base model 1, PSA + PV + PSAD + MR; Base model 2, PV + PSAD + MR. 1Base model 1 + TZV and Base model 1 + PZV had the same AUC.